The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance and regulatory changes. While it's challenging to predict with certainty which specific companies will go public, the following six HealthTech startups have the potential to be among the IPO candidates: Omada Health, Hinge Health, Sword Health, Doctolib, Aledade, Quantum Health

Exec Summary: Digital Health is a subset of Healthtech. Digital Health focuses on the individual patient, while Healthtech focuses on the...

Executive Summary The medical device market refers to the industry that encompasses the development, manufacturing, and distribution of...

Exec Summary: The digital health IPO boom of 2021 saw a surge of companies entering the public market, but the landscape has shifted...

HealthTech M&A multiples: Current Trends and Variables driving valuations Mid 2024 Exec Summary: The average revenue multiple for...

Exec Summary The average multiples in HealthTech M&A deals in 2024 have slightly increased compared to 2023, reflecting a more optimistic...

Exec Summary: Artificial emotional intelligence (AEI), also known as affective computing or emotion AI, is a field of artificial...

Palantir Technologies is a software company that specializes in big data analytics. The company has a number of products that are designed to help organisations make better decisions based on data. Palantir's products are used by a variety of industries, including healthcare. Palantir's plans for healthcare include using its products to help organisations improve patient care, reduce costs, and improve efficiency.

Exec Summary: The bridges and tunnels in healthcare technology are the infrastructure and systems that enable the efficient and reliable...

Exec Summary Patient engagement and patient portals are expected to play an increasingly important role in healthcare by 2030. As...

Exec Summary: The HealthTech IPO market is expected to recover in the summer of 2024 with a number of factors now starting to build and...

Private equity firms have traditionally focused on investing in large, high-growth healthcare technology companies. However, there is a growing opportunity for private equity firms to tap into the midtier of the healthtech landscape. These midtier companies have demonstrated a proof of concept, have won flagship customers, and are consistently profitable. However, they are unlikely to reach billion-dollar valuations. This makes them attractive targets for private equity fi

Exec Summary: HealthTech is defined by the World Health Organisation (WHO) as ‘the application of organised knowledge and skills in the...

Exec Summary: The average revenue multiple for HealthTech companies in 2023 is 4.5x. This is down from 6.5x in 2022, but still higher...

Exec Summary: There are a number of reasons why the Teladoc Livongo merger did not work. Some of the most notable reasons include: The...